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TO THE EDITOR
Nucleotide excision repair (NER) is a
versatile repair pathway capable of
removing a wide spectrum of helix-
distorting lesions including UV light-
induced cyclobutane pyrimidine dimers
(CPDs) and 6-4 photoproducts (6-4PP)
(de Laat et al., 1999; Friedberg, 2001).
NER can operate through two subpath-
ways: global genome nucleotide exci-
sion repair (GG-NER), which removes
DNA lesions throughout the genome,
and a specialized pathway termed
transcription-coupled nucleotide exci-
sion repair (TC-NER) dedicated to the
removal of transcription-blocking lesions
within transcribed DNA (Friedberg,
2001). Genetic disorders in NER cause
three distinct human diseases: xero-
derma pigmentosum (XP), Cockayne
syndrome (CS), and trichothiodystrophy
(Lehmann, 2003; Kraemer et al., 2007;
Niedernhofer, 2008).
Mouse models have been generated
to study the impact of NER deficiencies
on cancer incidence and defects of the
immune and neurological systems
(Wijnhoven et al., 2007). The impor-
tance of NER in protecting against
UVB-induced skin cancer is manifested
by elevated cancer incidence in com-
pletely NER-deficient Xpa/, GG-NER-
deficient Xpc/, and TC-NER-deficient
Csb/ mice, thus indicating that both
NER subpathways protect from UV-
induced skin cancer (Wijnhoven et al.,
2007). In contrast, CSB patients do not
appear to be predisposed to solar
carcinogenesis. The divergence in skin
cancer susceptibility between CS pa-
tients and CS-deficient mice has been
ascribed to more efficient GG-NER in
humans than in mice, therefore redu-
cing the risk of mutagenesis in CSB
patients (van der Horst et al., 1997; van
Zeeland et al., 2005). Alternatively, or
additionally, it has been argued that the
very limited life span (o12 years) of CS
patients would not allow any manifes-
tation of increased cancer susceptibi-
lity. One way to substantiate the first
hypothesis would be to increase the
GG-NER capacity of Csb/ mice to a
level comparable to that in humans and
to subject these mice to a UV-carcino-
genic regimen.
We have recently reported that
mouse keratinocytes show higher NER
capacity than dermal fibroblasts due to
an increased level of UV-damaged
DNA-binding protein (UV-DDB) (Pines
et al., 2009). UV-DDB is essential for
GG-NER of UV-induced CPD and
accelerates repair of 6-4PP (Moser
et al., 2005). Interestingly, keratino-
cytes derived from K14-Ddb2 trans-
genic mice expressing Ddb2 from the
human K14 promoter showed en-
hanced expression of Ddb2 in the
epidermis and an NER efficiency similar
to human keratinocytes (Pines et al.,
2009).
To assess whether efficient GG-NER
is responsible for the lack of enhanced
cancer susceptibility of CSB patients,
we used WT, K14-Ddb2, K14-Ddb2/
Csb/, and Csb/ mice to investigate
UV-induced skin carcinogenesis. Mice
were exposed to a daily UV dose of
40 Jm2 and after 7 weeks of treatment
squamous cell carcinomas (SCCs) were
already detected in 25% of the Csb/
mice (Figure 1a). All Csb/ mice devel-
oped SCCs by week 17. In contrast,
more than half of the K14-Ddb2/
Csb/ mice were still tumor free after
this period of time (Figure 1a). A
significant difference between Csb/
and K14-Ddb2/Csb/ mice was also
observed in the total yield of SCCs
(Figure 1b). No tumor development was
observed at this low dose of UV
radiation (40 Jm2 UVB) in WT and
K14-Ddb2 mice. Taken together, these
results indicate that the increased GG-
NER efficiency in mouse epidermal
Abbreviations: CPD, cyclobutane pyrimidine dimer; GG, global genome; NER, nucleotide excision
repair; SCC, squamous cell carcinoma; XP, xeroderma pigmentosum
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keratinocytes substantially reduces
UVB cancer susceptibility in the ab-
sence of functional TC-NER. The re-
duced onset of SCCs in K14-Ddb2/
Csb/ mice highlights the important
role of GG-NER in human skin as a
powerful backup or supplement to TC-
NER. The relative contribution of CPDs
and 6-4PPs to UVB-induced carcino-
genesis has been investigated using
transgenic mice that ubiquitously ex-
press CPD photolyase and 6-4PP photo-
lyase. CPD-photolyase mice exhibited,
in contrast to 6-4PP-photolyase mice,
an increased resistance to sunlight-
induced tumorigenesis, unequivocally
identifying CPDs as the principal cause
of nonmelanoma skin cancer (Jans
et al., 2005). The reduced UVB-in-
duced nonmelanoma skin cancer sus-
ceptibility of K14-Ddb2 mice is also
most likely associated with an en-
hanced repair of CPDs (Alekseev
et al., 2005). Hence, the marked
difference in tumor incidence between
Csb/ and K14-Ddb2/Csb/ probably
relates to a more efficient removal of
CPDs in the latter.
In CSB-deficient human skin, highly
efficient GG-NER is likely responsible
for repairing UV damages in both the
transcribed (TS) and nontranscribed strand
(NTS) of active genes, compensating for
the absence of TC-NER. To assess the
impact of efficient GG-NER on UV-
induced mutagenesis, we collected
SCCs derived from K14-Ddb2/Csb/
and Csb/ mice and exons 1–9 of
the p53 gene, known to contain
hot spots for UVB-induced mutations,
were sequenced (see Supplementary
Table S1 online). The analysis of
mutations in the p53 gene clearly
shows that efficient GG-NER can oper-
ate as a back-up system to remove UV
damages from the TS. In mice, defective
TC-NER leads to a strong mutational
bias toward the TS of the p53 gene (i.e.,
at UV-targeted dipyrimidine sites in the
TS; see Figure 2). In contrast, p53
mutation analysis in SCCs from UVB-
irradiated K14-Ddb2/Csb/ mice re-
veals an almost equal contribution of
p53 mutations by UV lesions in the TS
and NTS (Figure 2). Statistical compara-
tive analysis of the two different groups
shows a P-value of 0.03 (Po0.05 was
considered significant) (Figure 2). This
result indicates that GG-NER is able to
remove mutagenic photolesions effec-
tively from the TS (potential sites of
stalled transcription; Hendriks et al.,
2008). The absence of tumor formation
in WT and K14-Ddb2 mice prevented
further analysis of p53 mutations and
therefore the comparison among SCCs
from the different genotypes. Analyses
of strand-specific mutation in the p53
gene of tumors induced in WT mice
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Figure 1. Efficient global genome nucleotide excision repair (GG-NER) in Csb/ mice influences the susceptibility of hairless mice to UV-induced skin cancer.
To investigate the role of GG-NER in UV carcinogenesis in mice with transcription-coupled nucleotide excision repair (TC-NER)-defected background, we used
hairless K14Ddb2 transgenic mice in which a Ddb2 transgene was ectopically expressed at elevated levels under the control of human K14 promoter (Alekseev
et al., 2005), and hairless Csb/ knockout mice, in which the expression of the Csb gene was disrupted (van der Horst et al., 1997). Csb/ and K14-Ddb2 mice
were initially generated in C57BL/6JIco. Subsequently, K14-Ddb2 and Csb/ knockout hairless albino mice were generated by at least three generations
of crossing to albino hairless mice. We used 12 WT, 12 K14-Ddb2, 12 K14-Ddb2/Csb/, and 12 Csb/ mice for the UV-induced skin cancer experiments.
For UV carcinogenesis experiments, Philips TL-12/40W fluorescent tubes (Philips, Eindhoven, The Netherlands) were used. Hairless mice were exposed
daily to a UVB dose of 40 Jm2 approximating 0.08 MED for SKH1 mice (Rebel et al., 2001). Mice were kept in the animal facility of the Leiden University
Medical Center and all experiments were performed in accordance with legislation and approval of the university’s ethics committee. The number and size
of squamous cell carcinomas (SCCs) and papillomas were monitored weekly. (a) Prevalence of SCCs larger than 1mm; (b) yield of SCCs larger than 1mm;
(c) prevalence of papillomas larger than 1mm; (d) yield of papillomas larger than 1mm. Bars¼ SE.
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using higher doses of UVB have been
reported (Dumaz et al., 1997; van
Zeeland et al., 2005). These data
showed a prevalence of mutations in
p53 at UV-targeted sites in the NTS.
However, it cannot be excluded that
the strand distribution of mutations
is influenced by the dose of UVB
applied. Nevertheless, it is clear that
GG-NER only partly compensates for
the TC-NER defect of Csb/ mice,
as K14-Ddb2/Csb/ mice are more
cancer prone than WT mice. K14-
DDB2 transgenic mice ectopically ex-
press DDB2 from the human K14
promoter leading to constitutive en-
hanced expression of DDB2 in the
basal layer of epidermis (Pines et al.,
2009). In this respect it differs from the
situation in human cells where DDB2 is
induced upon UVB exposure in a p53-
dependent manner (Tan and Chu,
2002).
Csb/ and K14-Ddb2/Csb/ mice
also developed benign papillomas un-
der chronic UVB exposure (NB: these
papillomas are not precursors of SCCs).
Papillomas were detected 7–8 weeks
after the beginning of the treatment,
and nearly all mice of both genotypes
developed papillomas by week 15
(Figure 1c). During the chronic UVB
exposure, no difference in tumor devel-
opment or in total yield of papillomas
was observed between Csb/ and K14-
Ddb2/Csb/ mice (Figure 1d). Surpris-
ingly, the susceptibility to UVB-induced
skin papillomas in TC-NER-deficient
Csb/ mice was not corrected by the
K14-Ddb2 transgene.
The formation of papillomas is
strongly related to a TC-NER defect as
UV-irradiated NER-deficient Xpa/ and
TC-NER-deficient Csb/ mice develop
high frequencies of papillomas (Berg
et al., 2000), whereas TC-NER-proficient
XPC/ (Berg et al., 2000) or Ddb2/
(Alekseev et al., 2005) mice do not. The
development of papillomas is associated
with mutations in codon 12 of the Hras
gene (de Vries et al., 1998) caused by
photolesions at a CC site in the TS. Our
data clearly show that effective GG-NER
significantly reduces the development
and yield of SCCs, but not of papillomas.
To explain these findings, we speculate
that the enhanced GG-NER efficiency
mediated by ectopic expression of
DDB2 is not efficiently enough in
removing photolesions from the TS of
the highly transcribed Hras gene to
prevent transcription stalling at UV
photolesions. There is evidence that
stalled transcription machinery can im-
pair the assembly of GG-NER during
repair of the TS (Fousteri and Mullen-
ders, 2008). Alternatively, specific UV
damages might exist that can be effi-
ciently repaired by TC-NER but less well
by GG-NER as indicated by LM-PCR
analysis of the human Hras gene (Tor-
manen and Pfeifer, 1992). Finally, pa-
pillomas may arise from differentiated
epidermal cells with a reduced K14-
Ddb2 expression (i.e., the K14 promoter
is hardly active in differentiated kerati-
nocytes) by Ras-mediated dedifferentia-
tion (Birt et al., 1998; Pelengaris et al.,
1999; Harrisingh et al., 2004).
In conclusion, this study indicates
that efficient GG-NER protects against
UVB-induced skin cancer, providing an
explanation for the absence of en-
hanced skin cancer susceptibility in
CSB patients.
CONFLICT OF INTEREST
The authors state no conflict of interest.
Alex Pines1, Liesbeth Hameetman1,
Jillian de Wilde1, Sergey Alekseev1,
Frank R. de Gruijl2, Harry Vrieling1
and Leon H.F. Mullenders1
1Department of Toxicogenetics, Leiden
University Medical Center, RC Leiden, The
Netherlands and 2Department of Dermatology,
Leiden University Medical Center, RC Leiden,
The Netherlands
E-mail: l.mullenders@lumc.nl
TS NTS
M
ut
at
ed
 d
ip
yr
im
id
in
e 
sit
es
 (%
)
Csb –/– Csb –/–/
K14-Ddb2
100
90
80
70
60
50
40
20
10
0
30
Figure 2. Strand specificity of dipyrimidine sites mutated in the p53 gene of squamous cell carcinoma
(SCC) tumors induced by UVB irradiation. Fresh frozen SCCs from Csb/ (n¼13 tumors) and
K14-Ddb2/Csb/ (n¼ 15 tumors) mice were transferred to RNAlater-ICE (Ambion, Austin, TX) to
allow macrodissection of tumor-rich areas. These were subsequently subjected to RNA isolation using
the RNeasy mini kit (Qiagen, Valencia, CA) according to the manufacturer’s protocol. Mutation analysis
was performed for the coding sequences of exons 1– 9 of p53. Two different primer sets were used:
forward 50-CCTGGCTAAAGTTCTGTAGC-30 and reverse 50- GCCTGTCTTCCAGATACTCG-30 for p53-1
(exons 1–6), and forward 50- GCAGAGACCTGACAACTATC-30 and reverse 50- AGAGGCGCTTGTG
CAGGTG-30 for p53-2 (exons 4–9). For gene-specific first-strand cDNA synthesis, 2 mg total RNA was
reverse transcribed using SuperScript III Reverse Transcriptase (Invitrogen, Carlsbad, CA) according
to the manufacturer’s instructions with the exception that oligo(dT)20 was replaced by either primer
reverse p53-1 or reverse p53-2. PCR was performed under standard conditions, and products were
sequenced at the Leiden Genome Technology Center (http://www.lgtc.nl) and analyzed with the
Mutation Explorer version 3.10 software package (Softgenetics, State College, PA). NM_011640
reference sequence was used as a control sequence for comparison. The percentage of mutants with
a dipyrimidine site at the position where a base pair change was observed in either the transcribed
strand (TS) or in the nontranscribed strand (NTS) is indicated. The results of the mutation analysis
were combined with a previously published series by our research group (van Zeeland et al., 2005)
for statistical analysis in SPSS version 16.0 (SPSS, Chicago, IL). Pearson’s w2-test was performed to
compare the different groups, where a P-value o0.05 was considered significant.
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